chr15-41351121-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016359.5(NUSAP1):c.440T>A(p.Val147Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000059 in 1,610,426 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016359.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NUSAP1 | NM_016359.5 | c.440T>A | p.Val147Asp | missense_variant | 4/11 | ENST00000559596.6 | NP_057443.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NUSAP1 | ENST00000559596.6 | c.440T>A | p.Val147Asp | missense_variant | 4/11 | 1 | NM_016359.5 | ENSP00000453403 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000789 AC: 12AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000110 AC: 27AN: 244362Hom.: 0 AF XY: 0.0000604 AC XY: 8AN XY: 132556
GnomAD4 exome AF: 0.0000569 AC: 83AN: 1458250Hom.: 0 Cov.: 31 AF XY: 0.0000496 AC XY: 36AN XY: 725332
GnomAD4 genome AF: 0.0000789 AC: 12AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74358
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2022 | The c.440T>A (p.V147D) alteration is located in exon 4 (coding exon 4) of the NUSAP1 gene. This alteration results from a T to A substitution at nucleotide position 440, causing the valine (V) at amino acid position 147 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at